News
Ali KhademhosseiniProf. Ali Khademhosseini is a professor of biomedical engineering and medicine at Harvard Medical School and a faculty member at the Harvard–Massachusetts Institute of Technology (MIT) Division of Health Science and Technology and at Brigham and Women’s Hospital, as well as an…
Introduction
Therapeutically relevant proteins such as antibodies, growth factors, and enzymes play an increasing role in the treatment of malignant and autoimmune diseases. However, they often suffer from insufficient stability and poor bioavailability. A suitable method to increase protein…
Vinod LabhasetwarDDTR First Impact Factor 1.887
We are pleased to announce the first DDTR impact factor (IF) of 1.887. This two-year IF is based on total number of citations in 2015 for the articles published in 2014 and 2013. The five-year IF is 1.917, which is the average number of times…
Attendees listening attentively to the exciting scientific sessions.The CRS Canadian Local Chapter (CC-CRS) had yet another successful meeting in Vancouver, British Columbia, bringing in members from across the country. Held jointly with the Canadian Society for Pharmaceutical Sciences (CSPS), the…
On April 21 and 22, 2016, Monash Institute of Pharmaceutical Sciences (MIPS) in Melbourne hosted the 2016 Joint Annual Australian–New Zealand CRS Student Workshop
Zach Houston finishes his presentation in front of the magnificent Sissons Mural at Monash Parkville campus.under the theme “Crossing…
Introduction
Long-acting injectable (LAI) (pro)drug nano-/microsuspensions—aqueous dispersions of pure (pro)drug nano-/microcrystals—have shown potential as a drug delivery strategy over the past decade and are now recognized as an attractive formulation option for poorly water-soluble drug…
